Upscaling and preclinical evaluation for commercialization of a novel and affordable anti-fungal drug product
INR 50 Lakhs is funded by BIRAC/DBT under the Biotechnology Ignition Grant (BIG-23) scheme (Jan 2024 - July 2025).
Novel Therapeutic approaches for the treatment of Leukemia
INR 42 Lakhs is funded by ICMR for this project (2021 - 2024).
Development & optimization of stable anti-leukemic drug loaded long circulating liposomes
INR 30 Lakhs is funded by the Parenteral Drug Association, India Chapter for this project (2020 - 2023).
Development, optimization and evaluation of stable multidose injectable formulation of anticancer drug
INR 22 Lakhs is funded by the Industry for this project (July 2023- June 2025).
Novel formulation for oral bioavailability enhancement of anticancer drug
INR 21 Lakhs is funded by Slayback Pharma for this project (2020- 2022).
Exploring the synergistic benefits of co delivering angiogenesis and DNMT inhibitors using nanoliposomes for pancreatic cancer treatment
INR 20 Lakhs is funded by CDRF-BITS for this project (August 2024- July 2026). This project is co-supervised by Prof. Kumar Pranav Narayan.
Surface Modified Nanoparticulate Carrier System for the Effective Delivery of Antileukemic Drug
INR 10 Lakhs is funded by BITS Pilani under the Additional Competitive Research Grant scheme (2019-2021).
Development and characterization of a novel lipid based Nano emulsion for parenteral drug delivery
INR 8.2 Lakhs is funded by Slayback Pharma for this project (2020-2022).
Development & characterization of nano-emulsion based drug product for the management of emetogenic cancer chemotherapy
INR 7 Lakhs is funded by Slayback Pharma for this project (2018-2020).
Long-Acting Injectables (LAI)
INR 5.3 Lakhs is funded by Novartis Healthcare for this project (2021-2023).
Development, Optimization and Characterization of nanostructured carrier system for effective delivery of anticancer therapeutics
INR 2 Lakhs is funded by BITS Pilani under the Research Initiation Grant for this project (2018-2020).
An Institute of Eminence
